Long-term exposure to telmisartan as monotherapy or combination therapy: Efficacy and safetyShow others and affiliations
2002 (English)In: Blood Pressure, ISSN 0803-7051, E-ISSN 1651-1999, Vol. 11, no 3, p. 173-181Article in journal (Refereed) Published
Abstract [en]
This multicentre, open-label extension study to four controlled trials involved 888 patients with mild-to-moderate primary hypertension. Patients received telmisartan 40-80 mg once daily with add-on hydrochlorothiazide (HCTZ, 12.5-25 mg) if necessary and/or other antihypertensives to achieve diastolic blood pressure (DBP) control (
Place, publisher, year, edition, pages
2002. Vol. 11, no 3, p. 173-181
Keywords [en]
combination treatment, primary hypertension-controlled trial, mono-therapy, telmisartan, hydrochlorothiazide, long-term safety, efficacy
National Category
Natural Sciences
Identifiers
URN: urn:nbn:se:liu:diva-48870OAI: oai:DiVA.org:liu-48870DiVA, id: diva2:269766
2009-10-112009-10-112017-12-12